General
Preferred name
ALANYL GLUTAMINE
Synonyms
Ala-Gln ()
Dipeptiven ()
l-alanyl-l-glutamine ()
Glutamine dipeptide ()
L-Alanyl-L-Glutamine ()
Glutamax ()
N(2)-l-alanyl-levoglutamide ()
L-alanyl-l-glutamine amino acid ()
FEMA NO. 4712 ()
L-alanyl-l-glutamine ()
Dipeptamin ()
Sustamine ()
Alanyl-glutamine dipeptide ()
P&D ID
PD071836
CAS
39537-23-0
Tags
available
drug
Drug indication
Mucositis
Coronary artery disease
Drug Status
approved
investigational
Max Phase
3.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
L-Alanyl-L-glutamine (Ala-Gln), a dipeptide composed of alanine and Gln, is an alternative supplement to L-glutamine in the production of biopharmaceuticals with better solubility and stability than glutamine (Gln).
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
13
Cayman Chemical Bioactives
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
MedChem Express Bioactive Compound Library
Natural product-based probes and drugs
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
43
Molecular Weight
217.11
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
4
Rotatable Bonds
6
Ring Count
0
Aromatic Ring Count
0
cLogP
-1.83
TPSA
135.51
Fraction CSP3
0.62
Chiral centers
2.0
Largest ring
0.0
QED
0.41
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
Endogenous Metabolite
Biosynthetic Origin
Other (Amino Acid)
Therapeutic Indication
Mucositis
Pathway
Metabolism
Metabolic Enzyme/Protease
Source data
